Print this page    •   Back to Web version of article

What's New in the U.S. HHS Antiretroviral Therapy Guidelines for Adults and Adolescents

May 1, 2014

Revisions to the February 12, 2013, version of the guidelines include both a new section and key updates to existing sections. Significant updates are highlighted throughout the PDF version of the document.


New Section

Cost Considerations and Antiretroviral Therapy


Key Updates to Existing Sections

The following are key updates to existing sections of the guidelines.


Change in Recommendations on Frequency of CD4 Count Monitoring

This change can be found in the "Laboratory Testing: HIV-RNA (Viral Load) and  CD4 Count Monitoring" section.


Change in Classification of Recommendations for Initial Treatment From "Preferred Regimens" to "Recommended Regimens"

This change can be found in the "What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient" section.


Emphasis on Key Principles to Follow When Switching ARV Drugs in the Setting of Viral Suppression

The "Regimen Simplification" section of the previous guideline has been updated with a new title -- "Regimen Switching in the Setting of Viral Suppression" -- and includes the following key revisions.


Addition of a New Table That Provides Recommendations on ARV Drug Options When Switching ARV Drugs Because of Adverse Effects


Additional Updates

Minor revisions have also been made to the following sections:




This article was provided by AIDSinfo. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/66414/whats-new-in-the-us-dhhs-antiretroviral-therapy-gu.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.